Ultherapy PRIME acquires FDA approval
Pharmaceutical company Merz Aesthetics has received US Food and Drug Administration (FDA) approval for Ultherapy PRIME for skin laxity on the knees. The company shares that this approval on the
Pharmaceutical company Merz Aesthetics has received US Food and Drug Administration (FDA) approval for Ultherapy PRIME for skin laxity on the knees. The company shares that this approval on the
Belotero Balance hyaluronic acid (HA) dermal filler from pharmaceutical company Merz Aesthetics has received US Food and Drug Administration (FDA) approval for under-eye treatments.
Aesthetic supplier Cosmeditech has launched Exciplex to treat autoimmune skin conditions.
The US Food and Drug Administration (FDA) has issued a safety communication regarding the use of needle-free injection devices for fillers.
Reimagine your business model with Celluma Light Therapy
Aesthetic device manufacturer, Solta Medical Ltd, has released the Thermage FLX system, a radiofrequency device designed to tighten skin.
Hyaluronic acid dermal filler Restylane Kysse, produced by global pharmaceutical company Galderma, received high subject and partner satisfaction, according to new phase 4 study results.
Hyaluronic acid dermal filler Restylane Kysse has been approved by the US Food and Drug Administration (FDA) for lip augmentation and the correction of upper perioral rhytids.
The Food and Drug Administration (FDA) has approved AKLIEF (trifarotene) Cream 0.005% for the topical treatment of acne.